Kent Bondensgaard – Biography
Last update: April 7, 2026Executive profile
Kent was Vice President, Research at Kiniksa Pharmaceuticals, and Director, Antibody Technology at Novo Nordisk. Kent Bondensgaard joined Alloy Therapeutics in 2023.
Kent Bondensgaard is currentlySenior Vice President of Antibody Discovery Services at Alloy Therapeutics - View - Alloy Therapeutics org chart
Create your alert
to follow the career of Kent Bondensgaard.
Education
Kent Bondensgaard has a Graduate Certificate in Business Administration from Copenhagen Business School.
They have also studied at Copenhagen Business School :
Find more alumni from Copenhagen Business School
More about Kent Bondensgaard
Selected links
Do you need to know more about Kent Bondensgaard? More results.
Participate
Social media
- Kent Bondensgaard on Google News, X (Twitter), LinkedIn, YouTube
- View the pictures of Kent Bondensgaard
The colleagues of Kent Bondensgaard
Company Colleagues
- At Alloy Therapeutics, Kent Bondensgaard has 22 colleagues including Errik Anderson (CEO & Chairman), Fabian Hansen (Director)…
Industry Colleagues
- In the Biotechnology industry, Kent Bondensgaard has 35,757 colleagues in 2,406 companies located in 42 countries. 16,856 executive movements have been recorded in the last 12 months. Learn more about Biotechnology.
Report an error
Update the org chart details of Kent Bondensgaard.
Get in Touch
Here are a few tips for establishing great contacts.
